ONTO, MRVL, MRNA: Potential Year-End Rally?

We see a strong rally into January that’s been confirmed by the current move up, notes Paul Schatz. He discusses how stocks slip to put major index winning streaks in jeopardy. He evaluates seasonal equity moves. He talks about how the main missing ingredient from October bottom was a spike in the VIX. He highlights how small caps were decimated by the strong dollar and recession expectations. He then goes over his stock picks which include Onto Innovation (ONTO), Marvell (MRVL), and Moderna (MRNA). Tune in to find out more about the stock market today.